½ÃÀ庸°í¼­
»óǰÄÚµå
1762272

´Ü¹éÁúüÇÐ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦Ç° À¯Çü, ¿ëµµ, ±â¼ú, Áö¿ªº° - ½ÃÀå ¿¹Ãø(2025-2034³â)

Proteomics Market Size, Share, Trends, Industry Analysis Report: By Product Type, Application, Technology, and Region - Market Forecast, 2025-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 120 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è ´Ü¹éÁúüÇÐ ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 908¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

´Ü¹éÁúüÇÐ ½ÃÀåÀº ´Ü¹éÁúÀÇ ±¸Á¶, ±â´É, »óÈ£ÀÛ¿ë, »ý¹°ÇÐÀû ½Ã½ºÅÛ ³»¿¡¼­ÀÇ º¯Çü µîÀ» Æ÷°ýÇÏ´Â ´Ü¹éÁúÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®ÀÌ Áß½ÉÀÔ´Ï´Ù. ÀÌ ºÐ¾ß´Â º¹ÀâÇÑ ¼¼Æ÷ °úÁ¤À» ±Ô¸íÇϰí Áúº´ÀÇ ºÐÀÚÀû ±â¹ÝÀ» ÀÌÇØÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ´Ü¹éÁúüÇÐÀº »ý¹°, Á¶Á÷, ¼¼Æ÷¿¡¼­ ƯÁ¤ ½Ã°£¿¡ ¹ßÇöµÇ´Â Àüü ´Ü¹éÁúÀ» ½Äº°Çϰí Á¤·®È­ÇÔÀ¸·Î½á ´Ù¾çÇÑ »ý¸í°úÇÐ ºÐ¾ßÀÇ ¹ßÀü¿¡ ÇʼöÀûÀÎ Áß¿äÇÑ Áö½ÄÀ» Á¦°øÇÕ´Ï´Ù. ½ÃÀå ¹üÀ§¿¡´Â ´Ü¹éÁú ¿¬±¸¿Í ±× ´Ù¾çÇÑ ÀÀ¿ë¿¡ Ȱ¿ëµÇ´Â ´Ù¾çÇÑ µµ±¸, ±â¼ú, ¼­ºñ½º°¡ Æ÷ÇԵ˴ϴÙ.

´Ü¹éÁúüÇÐ ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó Ä¡·á¸¦ È¿°úÀûÀ¸·Î Á¶Á¤Çϱâ À§ÇØ °³º° ´Ü¹éÁú ÇÁ·ÎÆÄÀÏ¿¡ ´ëÇÑ ´õ ±íÀº ÀÌÇØ°¡ ÇÊ¿äÇÕ´Ï´Ù. Á¦¾à ¹× »ý¸í°øÇÐ »ê¾÷Àº ½Å¾à Ÿ°Ù ¹ß±¼, ¹ÙÀÌ¿À¸¶Ä¿ ¹ß±¼, ½Å±Ô Ä¡·áÁ¦ °³¹ß¿¡ ÀÖ¾î ´Ü¹éÁúüÇп¡ Å©°Ô ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù.

Áú·®ºÐ¼®±â, Å©·Î¸¶Åä±×·¡ÇÇ¿Í °°Àº ºÐ¼® Àåºñ¿Í Á¤±³ÇÑ ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ¼ÒÇÁÆ®¿þ¾îÀÇ ±â¼ú ¹ßÀüÀ¸·Î ´Ü¹éÁú ºÐ¼®ÀÇ ´É·Â°ú È¿À²¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Çаè, Á¤ºÎ±â°ü, ¹Î°£´ÜüÀÇ ¿¬±¸°³¹ß Ȱµ¿¿¡ ´ëÇÑ ÅõÀÚ°¡ È®´ëµÇ°í ÀÖ´Â °Íµµ ´Ü¹éÁúüÇÐ ½ÃÀåÀÇ È®´ë¿Í Çõ½Å¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

´Ü¹éÁúüÇÐ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Á¦Ç° À¯Çüº°·Î´Â ½Ã¾à ¹× ¼Ò¸ðǰ ºÎ¹®ÀÌ ´Ü¹éÁúüÇÐ ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â Àü ¼¼°è ¸ðµç ¿¬±¸ ¹× ÀÀ¿ë ºÐ¾ßÀÇ ´Ü¹éÁúüÇÐ ½ÇÇè¿¡¼­ ÀÌ·¯ÇÑ Á¦Ç°ÀÌ ±âº»ÀûÀ̰í Áö¼ÓÀûÀ¸·Î ÇÊ¿äÇϱ⠶§¹®ÀÔ´Ï´Ù. ´Ü¹éÁúüÇÐ ºÐ¼®ÀÇ Áö¼ÓÀûÀΠƯ¼ºÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä°¡ Á¦Ç° À¯Çüº° ºÎ¹®¿¡¼­ ¼±µµÀûÀÎ À§Ä¡¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

¿ëµµº°·Î´Â ½Å¾à°³¹ß ºÐ¾ß°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÁÖ·Î ÀáÀçÀû ½Å¾à Ÿ°Ù ¹ß±¼ ¹× Áúº´ ±âÀü ±Ô¸í¿¡ ´Ü¹éÁúüÇÐÀÌ ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ°í Àֱ⠶§¹®À̸ç, ÀÌ´Â Àü ¼¼°èÀûÀ¸·Î ¸¹Àº ÅõÀÚ°¡ ÀÌ·ç¾îÁö°í ÀÖ´Â ÀǾàǰ R&D ÆÄÀÌÇÁ¶óÀο¡¼­ Áß¿äÇÑ ´Ü°èÀÔ´Ï´Ù.

±â¼úº°·Î´Â ´Ü¹éÁúÀÇ µ¿Á¤ ¹× Á¤·®È­¿¡ ÀÖ¾î Áú·® ºÐ¼® ±â¼úÀÌ ±¤¹üÀ§ÇÏ°Ô Áß¿äÇÑ ¿ªÇÒÀ» Çϰí Àֱ⠶§¹®¿¡ ºÐ±¤ÇÐ ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ Áö¿ªÀÇ ´Ù¾çÇÑ ´Ü¹éÁúüÇÐ ¿öÅ©Ç÷ο쿡¼­ ±× ´ÙÀç´Ù´ÉÇÔ°ú Çʼö¼ºÀÌ ÀÌ ±â¼ú ºÎ¹®ÀÇ ¿ìÀ§¸¦ È®°íÈ÷ Çϰí ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ´Ü¹éÁúüÇÐ ½ÃÀå ¼öÀÍ¿¡¼­ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖ¿ä ±â¾÷À¸·Î´Â Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies, Inc., Bruker Corporation, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Waters Corporation, SCIEX (part of Danaher Corporation), Merck KgaA µîÀÌ ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷Àº ´Ü¹éÁúüÇÐ ¿¬±¸ ¹× ÀÀ¿ë¿¡ ÇʼöÀûÀÎ Á¾ÇÕÀûÀÎ Á¦Ç°°ú ¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ´Ü¹éÁúüÇÐ ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ÇöȲ
  • ´Ü¹éÁúüÇÐ ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
      • ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ÁÖ¸ñ Áõ°¡
      • ÀǾàǰ ¹ß°ß°ú °³¹ßÀÇ Áøº¸
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
      • ´Ü¹éÁúüÇÐ ±â±â¿Í ½Ã¾àÀÇ °íºñ¿ë
  • PESTEL ºÐ¼®
  • ´Ü¹éÁúüÇÐ ½ÃÀå ¾ÖÇø®ÄÉÀÌ¼Ç µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ´Ü¹éÁúüÇÐ ½ÃÀå : Á¦Ç° À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ±â±â
  • ½Ã¾à°ú ¼Ò¸ðǰ
  • ¼­ºñ½º

Á¦6Àå ¼¼°èÀÇ ´Ü¹éÁúüÇÐ ½ÃÀå : ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • Drug Discovery
  • ÀÓ»ó Áø´Ü
  • ºÐÀÚ ÀÇÇÐ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ´Ü¹éÁúüÇÐ ½ÃÀå : ±â¼úº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ±â±â
  • X¼± °áÁ¤±¸Á¶ ºÐ¼®
  • ºÐ±¤¹ý
  • Å©·Î¸¶Åä±×·¡ÇÇ
  • ´Ü¹éÁú ºÐȹ ½Ã½ºÅÛ
  • Àü±â¿µµ¿
  • Ç¥¸é ÇöóÁ °ø¸í(SPR) ½Ã½ºÅÛ

Á¦8Àå ¼¼°èÀÇ ´Ü¹éÁúüÇÐ ½ÃÀå : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
    • ´Ü¹éÁúüÇÐ ½ÃÀå Æò°¡ : Áö¿ªº°, 2020-2034³â
  • ºÏ¹Ì
    • ºÏ¹Ì : Á¦Ç° À¯Çüº°, 2020-2034³â
    • ºÏ¹Ì : ¿ëµµº°, 2020-2034³â
    • ºÏ¹Ì : ±â¼úº°, 2020-2034³â
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ : Á¦Ç° À¯Çüº°, 2020-2034³â
    • À¯·´ : ¿ëµµº°, 2020-2034³â
    • À¯·´ : ±â¼úº°, 2020-2034³â
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Á¦Ç° À¯Çüº°, 2020-2034³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿ëµµº°, 2020-2034³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±â¼úº°, 2020-2034³â
    • Áß±¹
    • Àεµ
    • ¸»·¹À̽þÆ
    • ÀϺ»
    • Àεµ³×½Ã¾Æ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Á¦Ç° À¯Çüº°, 2020-2034³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿ëµµº°, 2020-2034³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±â¼úº°, 2020-2034³â
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : Á¦Ç° À¯Çüº°, 2020-2034³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¿ëµµº°, 2020-2034³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±â¼úº°, 2020-2034³â
    • ¸ß½ÃÄÚ
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • È®´ë¿Í Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦10Àå ±â¾÷ °³¿ä

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc
  • Bruker Corporation
  • Danaher Corporation
  • Merck KGaA
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • SCIEX
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
ksm

The global proteomics market size is expected to reach USD 90.83 billion by 2034, according to a new study by Polaris Market Research. The report "Proteomics Market Size, Share, Trends, Industry Analysis Report: By Product Type (Instruments, Reagents & Consumables, and Services), Application, Technology, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The proteomics market is centered around the comprehensive analysis of proteins, encompassing their structures, functions, interactions, and modifications within biological systems. This field plays a pivotal role in unraveling the complexities of cellular processes and understanding the molecular basis of diseases. By identifying and quantifying the entire set of proteins expressed by an organism, tissue, or cell at a specific time, proteomics provides crucial insights that are essential for advancements in various life science disciplines. The market's scope includes a wide array of tools, technologies, and services utilized in protein research and its diverse applications.

The proteomics market growth is driven by several key factors. The increasing focus on personalized medicine necessitates a deeper understanding of individual protein profiles to tailor treatments effectively. The pharmaceutical and biotechnology industries heavily rely on proteomics for drug target identification, biomarker discovery, and the development of novel therapeutics.

Technological advancements in analytical instruments, such as mass spectrometry and chromatography, along with sophisticated bioinformatics software, are enhancing the capabilities and efficiency of proteomic analyses. Furthermore, growing investments in research and development activities across academic institutions, government bodies, and private organizations continue to fuel the proteomics market expansion and innovation.

Proteomics Market Report Highlights

By product type, the reagents & consumables segment holds the largest proteomics market share due to the fundamental and continuous need for these products in proteomic experiments across all research and application areas globally. This consistent demand, driven by the ongoing nature of proteomic analysis, establishes its leading position in the product type segmentation.

By application, the drug discovery segment accounts for the largest market share. This is primarily because of the extensive application of proteomics in identifying potential drug targets and understanding disease mechanisms, which are critical steps in the heavily invested pharmaceutical research and development pipelines worldwide.

By technology, the spectroscopy segment commands the largest market share, largely due to the widespread and crucial role of mass spectrometry techniques in protein identification and quantification. Its versatility and essentiality in various proteomic workflows across different regions solidify its dominance in the technology segmentation.

By region, North America holds the largest share of the proteomics market revenue. The Asia Pacific market is projected to exhibit the highest growth rate during the forecast period.

A few major players actively contributing to the market include Thermo Fisher Scientific Inc.; Danaher Corporation; Agilent Technologies, Inc.; Bruker Corporation; PerkinElmer, Inc.; Bio-Rad Laboratories, Inc.; QIAGEN N.V.; Waters Corporation; SCIEX (part of Danaher Corporation); and Merck KgaA. These entities offer a comprehensive range of products and services essential for proteomic research and applications.

Polaris Market Research has segmented the market report on the basis of product type, application, technology, and region:

By Product Type Outlook (Revenue-USD Billion, 2020-2034)

Instruments

Protein Microarray

Spectrometry

Mass Spectrometry

NMR Spectroscopy

Chromatography

HPLC Systems

Ion Chromatography

Affinity Chromatography

Supercritical Fluid Chromatography

Electrophoresis

Gel Electrophoresis

Capillary Electrophoresis

Surface Plasmon Resonance

X-ray Crystallography

Protein Fractionation Systems

Reagents & Consumables

Microarray

Spectroscopy

X-ray Crystallography

Chromatography

Electrophoresis

Immunoassay

Protein Fractionation Reagents

Services

By Application Outlook (Revenue-USD Billion, 2020-2034)

Drug Discovery

Clinical Diagnosis

Molecular Medicine

Others

By Technology Outlook (Revenue-USD Billion, 2020-2034)

Microarray Instruments

X-Ray Crystallography

Spectroscopy

Chromatography

Protein Fractionation Systems

Electrophoresis

Surface Plasma Resonance (SPR) Systems

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of the Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Proteomics Market Insights

  • 4.1. Proteomics Market - Market Snapshot
  • 4.2. Proteomics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Focus on Personalized Medicine
      • 4.2.1.2. Advancements in Drug Discovery and Development
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of proteomics instruments and reagents
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Proteomics Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Proteomics Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Proteomics Market, by Product Type, 2020-2034 (USD Billion)
  • 5.3. Instruments
    • 5.3.1. Global Proteomics Market, by Instruments, by Region, 2020-2034 (USD Billion)
    • 5.3.2. Protein Microarray
    • 5.3.3. Spectrometry
      • 5.3.3.1. Mass Spectrometry
      • 5.3.3.2. NMR Spectroscopy
    • 5.3.4. Chromatography
      • 5.3.4.1. HPLC Systems
      • 5.3.4.2. Ion Chromatography
      • 5.3.4.3. Affinity Chromatography
      • 5.3.4.4. Supercritical Fluid Chromatography
    • 5.3.5. Electrophoresis
      • 5.3.5.1. Gel Electrophoresis
      • 5.3.5.2. Capillary Electrophoresis
    • 5.3.6. Surface Plasmon Resonance
    • 5.3.7. X-ray Crystallography
    • 5.3.8. Protein Fractionation Systems
  • 5.4. Reagents & Consumables
    • 5.4.1. Global Proteomics Market, by Reagents & Consumables, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Microarray
    • 5.4.3. Spectroscopy
    • 5.4.4. X-ray Crystallography
    • 5.4.5. Chromatography
    • 5.4.6. Electrophoresis
    • 5.4.7. Immunoassay
    • 5.4.8. Protein Fractionation Reagents
  • 5.5. Services
    • 5.5.1. Global Proteomics Market, by Services, by Region, 2020-2034 (USD Billion)

6. Global Proteomics Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Proteomics Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Drug Discovery
    • 6.3.1. Global Proteomics Market, by Drug Discovery, by Region, 2020-2034 (USD Billion)
  • 6.4. Clinical Diagnosis
    • 6.4.1. Global Proteomics Market, by Clinical Diagnosis, by Region, 2020-2034 (USD Billion)
  • 6.5. Molecular Medicine
    • 6.5.1. Global Proteomics Market, by Molecular Medicine, by Region, 2020-2034 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Proteomics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Proteomics Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Proteomics Market, by Technology, 2020-2034 (USD Billion)
  • 7.3. Microarray Instruments
    • 7.3.1. Global Proteomics Market, by Microarray Instruments, by Region, 2020-2034 (USD Billion)
  • 7.4. X-Ray Crystallography
    • 7.4.1. Global Proteomics Market, by X-Ray Crystallography, by Region, 2020-2034 (USD Billion)
  • 7.5. Spectroscopy
    • 7.5.1. Global Proteomics Market, by Spectroscopy, by Region, 2020-2034 (USD Billion)
  • 7.6. Chromatography
    • 7.6.1. Global Proteomics Market, by Chromatography, by Region, 2020-2034 (USD Billion)
  • 7.7. Protein Fractionation Systems
    • 7.7.1. Global Proteomics Market, by Protein Fractionation Systems, by Region, 2020-2034 (USD Billion)
  • 7.8. Electrophoresis
    • 7.8.1. Global Proteomics Market, by Electrophoresis, by Region, 2020-2034 (USD Billion)
  • 7.9. Surface Plasma Resonance (SPR) Systems
    • 7.9.1. Global Proteomics Market, by Surface Plasma Resonance (SPR) Systems, by Region, 2020-2034 (USD Billion)

8. Global Proteomics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Proteomics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Proteomics Market - North America
    • 8.3.1. North America: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Proteomics Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.3.4. Proteomics Market - U.S.
      • 8.3.4.1. U.S.: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.3.5. Proteomics Market - Canada
      • 8.3.5.1. Canada: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Proteomics Market, by Technology, 2020-2034 (USD Billion)
  • 8.4. Proteomics Market - Europe
    • 8.4.1. Europe: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Proteomics Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.4. Proteomics Market - UK
      • 8.4.4.1. UK: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.5. Proteomics Market - France
      • 8.4.5.1. France: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.6. Proteomics Market - Germany
      • 8.4.6.1. Germany: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.7. Proteomics Market - Italy
      • 8.4.7.1. Italy: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.8. Proteomics Market - Spain
      • 8.4.8.1. Spain: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.9. Proteomics Market - Netherlands
      • 8.4.9.1. Netherlands: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.10. Proteomics Market - Russia
      • 8.4.10.1. Russia: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.11. Proteomics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Proteomics Market, by Technology, 2020-2034 (USD Billion)
  • 8.5. Proteomics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Proteomics Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.4. Proteomics Market - China
      • 8.5.4.1. China: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.5. Proteomics Market - India
      • 8.5.5.1. India: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.6. Proteomics Market - Malaysia
      • 8.5.6.1. Malaysia: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.7. Proteomics Market - Japan
      • 8.5.7.1. Japan: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.8. Proteomics Market - Indonesia
      • 8.5.8.1. Indonesia: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.9. Proteomics Market - South Korea
      • 8.5.9.1. South Korea: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.10. Proteomics Market - Australia
      • 8.5.10.1. Australia: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.11. Proteomics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Proteomics Market, by Technology, 2020-2034 (USD Billion)
  • 8.6. Proteomics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Proteomics Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.4. Proteomics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.5. Proteomics Market - UAE
      • 8.6.5.1. UAE: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.6. Proteomics Market - Israel
      • 8.6.6.1. Israel: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.7. Proteomics Market - South Africa
      • 8.6.7.1. South Africa: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.8. Proteomics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Proteomics Market, by Technology, 2020-2034 (USD Billion)
  • 8.7. Proteomics Market - Latin America
    • 8.7.1. Latin America: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Proteomics Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.4. Proteomics Market - Mexico
      • 8.7.4.1. Mexico: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.5. Proteomics Market - Brazil
      • 8.7.5.1. Brazil: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.6. Proteomics Market - Argentina
      • 8.7.6.1. Argentina: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Proteomics Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.7. Proteomics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Proteomics Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Proteomics Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Proteomics Market, by Technology, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Agilent Technologies, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bio-Rad Laboratories, Inc
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development .
  • 10.3. Bruker Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Danaher Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Merck KGaA
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. PerkinElmer, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. QIAGEN N.V.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. SCIEX
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Thermo Fisher Scientific Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Waters Corporation
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦